[Therapeutic approach to chronic hepatitis B and C in the dawn of the third millenium].
We try to illustrate the latest developments in epidemiology, pathogenesis and natural history of hepatitis B and C virus infection. Practical management of the patient with chronic B and C liver disease is presented. Universal hepatitis B vaccination should be encouraged in order to reduce to zero morbidity and mortality attributable to liver disease and its complications. Patients at risk for hepatitis B or C infection should be screened and notified about their evolutive risk and the therapeutic possibilities.
Adler
M
M
Service de Gastro-Entérologie et d'Hépato-Pancréatologie, Hôpital Erasme, U.L.B.
Bourgeois
N
N
D006528:Carcinoma, Hepatocellular / Q000821:virology; D018450:Disease Progression; D005544:Forecasting; D014943:Global Health; D019694:Hepatitis B, Chronic / Q000145:classification / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D019698:Hepatitis C, Chronic / Q000145:classification / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000821:virology; D008113:Liver Neoplasms / Q000821:virology; D008403:Mass Screening; D009017:Morbidity; D020380:Needs Assessment; D011159:Population Surveillance; D015995:Prevalence; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014611:Vaccination